NCT06505447

Brief Summary

A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Dec 2024Jan 2027

First Submitted

Initial submission to the registry

July 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

December 6, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

2.1 years

First QC Date

July 11, 2024

Last Update Submit

March 18, 2026

Conditions

Keywords

Sleep disruptioncircadian rhythmcritical carepediatrics

Outcome Measures

Primary Outcomes (1)

  • Feasibility of monitoring the sleep and circadian rhythm of critically ill children

    The number of days that reliable sleep and CR data are obtained using an actigraph and serial salivary melatonin assays

    PICU Day 1 through 4

Secondary Outcomes (2)

  • Feasibility of providing daytime light exposure

    PICU Day 2 through 4

  • Feasibility of restricting nutrition to daytime hours

    PICU Day 2 through 4

Study Arms (3)

Phase 1: standard of care

NO INTERVENTION

10 children will be enrolled in the first phase related to determining if using actigraphy and timed saliva melatonin samples can be a feasible way to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old while they receive routine critical care.

Phase 2: Daytime light exposure

EXPERIMENTAL

10 children will undergo the same sleep monitoring and salivary melatonin sampling as phase 1 while receiving timed exposure to a light box of 10,000 lux within 3 feet of their hospital bed for PICU days #2, 3 and 4.

Other: Daytime light exposure

Phase 3: Daytime restricted feeding

EXPERIMENTAL

10 children will undergo the same sleep monitoring and salivary melatonin sampling as phase 1 while attempting to limit all nutrition (parental or enteral) to being provided during the normal hours that the child is awake at home on PICU days #2, 3, 4.

Other: Daytime restricted feeding

Interventions

Participants will be exposed to a 10,000 lux light source within 3 feet of their face/eyes to promote the natural circadian rhythm for 2-3 hours from 10am to 12/1pm depending on their nap time at home

Also known as: Light therapy
Phase 2: Daytime light exposure

Participant's nutrition, parenteral or enteral, will be restricted to the hours when they are normally awake at home.

Phase 3: Daytime restricted feeding

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child age 3 to 6 years old on the day of PICU admission
  • English-speaking parent at the bedside
  • Child expected to remain in the PICU over 24 to 48 hours

You may not qualify if:

  • Child is in end-of-life care
  • The child is receiving neuromuscular blockade for any reason
  • Caregiver or parent not at the bedside

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John R. Oishei Children's Hospital

Buffalo, New York, 14203, United States

RECRUITING

Related Publications (6)

  • Traube C, Silver G, Gerber LM, Kaur S, Mauer EA, Kerson A, Joyce C, Greenwald BM. Delirium and Mortality in Critically Ill Children: Epidemiology and Outcomes of Pediatric Delirium. Crit Care Med. 2017 May;45(5):891-898. doi: 10.1097/CCM.0000000000002324.

    PMID: 28288026BACKGROUND
  • Kamdar BB, Kamdar BB, Needham DM. Bundling sleep promotion with delirium prevention: ready for prime time? Anaesthesia. 2014 Jun;69(6):527-31. doi: 10.1111/anae.12686. No abstract available.

    PMID: 24813131BACKGROUND
  • Kudchadkar SR, Aljohani OA, Punjabi NM. Sleep of critically ill children in the pediatric intensive care unit: a systematic review. Sleep Med Rev. 2014 Apr;18(2):103-10. doi: 10.1016/j.smrv.2013.02.002. Epub 2013 May 21.

    PMID: 23702219BACKGROUND
  • Pun BT, Balas MC, Barnes-Daly MA, Thompson JL, Aldrich JM, Barr J, Byrum D, Carson SS, Devlin JW, Engel HJ, Esbrook CL, Hargett KD, Harmon L, Hielsberg C, Jackson JC, Kelly TL, Kumar V, Millner L, Morse A, Perme CS, Posa PJ, Puntillo KA, Schweickert WD, Stollings JL, Tan A, D'Agostino McGowan L, Ely EW. Caring for Critically Ill Patients with the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 Adults. Crit Care Med. 2019 Jan;47(1):3-14. doi: 10.1097/CCM.0000000000003482.

    PMID: 30339549BACKGROUND
  • Berger J, Zaidi M, Halferty I, Kudchadkar SR. Sleep in the Hospitalized Child: A Contemporary Review. Chest. 2021 Sep;160(3):1064-1074. doi: 10.1016/j.chest.2021.04.024. Epub 2021 Apr 22.

    PMID: 33895129BACKGROUND
  • Hassinger AB, Mody K, Gomez R, Wrotniak BH, Falkowski K, Breuer R, Mennie C, Flagg LK. Validation of the Survey of Sleep Quality in the Pediatric Intensive Care Unit (SSqPICU). J Clin Sleep Med. 2024 Aug 1;20(8):1251-1258. doi: 10.5664/jcsm.11116.

    PMID: 38456806BACKGROUND

MeSH Terms

Conditions

ParasomniasCritical Illness

Interventions

Phototherapy

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Amanda B Hassinger, MD

CONTACT

Haiping Qiao, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: Three phase single center pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor of Pediatric Sleep Medicine

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 17, 2024

Study Start

December 6, 2024

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

March 23, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Our institution has no current ability to create de-identified data sets available to share at this time, but this could change by study completion.

Locations